European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 134, Issue 1 , Pages 57-66, September 2007

Use of oral contraceptives in Germany: Prevalence, determinants and use-associated health correlates:

Results of National Health Surveys from 1984 to 1999

  • Yong Du

      Affiliations

    • RKI 22, Pharmacoepidemiology, Robert-Koch Institute, Seestr. 10, D-13353 Berlin, Germany
    • DAAD-scholarship holder, on leave of Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 200032, China.
  • ,
  • Hans-Ulrich Melchert

      Affiliations

    • RKI 22, Pharmacoepidemiology, Robert-Koch Institute, Seestr. 10, D-13353 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 30 45473170; fax: +49 30 45473211.
  • ,
  • Monika Schäfer-Korting

      Affiliations

    • Institute of Pharmacy, Department of Pharmacology and Toxicology, Free University Berlin, Königin-Luise-Str. 2+4, D-14191 Berlin, Germany

Received 7 November 2005; received in revised form 12 December 2006; accepted 12 January 2007. published online 10 February 2007.

Abstract 

Objectives

To describe oral contraceptive (OC) use, its determinants and use-associated health correlates from 1984 to 1999 in Germany.

Study design

Cross-sectional comparison was performed for socioeconomic factors, personal lifestyle and use-associated health correlates between 1862 OC users and 2625 age-matched nonusers identified from five German National Health Surveys. Regression models were used to obtain the determinants of OC use.

Results

While in women aged 25–49 years OC use remained nearly constant in the western part of Germany from 1984 to 1999 (17.3–20.1%), it declined greatly in the eastern part from 43.0% in 1991 to 32.3% in 1999. Cross-sectional comparison and regression analysis suggested that OC users did not differ from nonusers in most selected personal and socioeconomic factors. OC users showed generally a better health profile than age-matched nonusers with more satisfaction with health, higher quality of life and no significant difference in history of cardiovascular diseases despite slightly higher prevalence of hypertension and hyperlipidemia that are of little clinical significance.

Conclusions

OC use seems to be generally safe. Whether the better health profiles found in OC users are the results of OC use or effects of healthy users, or both, should be further studied.

Keywords: Oral contraceptives, Population representative data, National Health Surveys, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-2115(07)00036-X

doi:10.1016/j.ejogrb.2007.01.007

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 134, Issue 1 , Pages 57-66, September 2007